
    
      The main outcome measure used is the SANS (Scale for the Assessment of Negative Symptoms.
      This is a semi strucutured interview which provides scores from 0-70. This is administered at
      baseline, week 2, 3, 5 and 6.

      Other outcome measures administered are (frequency mentioned above): PANSS (Positive and
      Negative Syndrome Scale) and the Calgery Depression Scale for Schizophrenia, A cognitive
      battery is also administered.

      Inclusion Criteria:

        -  Diagnostic and Statistical Manual-IV diagnosis of schizophrenia or schizoaffective
           disorder, age over 18

        -  Persistent negative symptoms of moderate to severe intensity

        -  Failure to respond to a minimum of two antipsychotic medications

        -  No increase or initiation of new antipsychotic therapy in the four weeks prior to
           entering the trial Exclusion Criteria

        -  Prominent positive symptoms

        -  Have an unstable medical condition, neurological disorder or any history of seizure
           disorder or are currently pregnant or lactating

        -  Previous brain injury or surgery, any metal clips, plates or other metal items in the
           head, cardiac pacemaker

        -  Subjects at high risk of violence or suicide as determined by the investigator and
           treating clinicians

        -  Substance dependence
    
  